Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2012, Article ID 614349, 6 pages
http://dx.doi.org/10.1155/2012/614349
Clinical Study

Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma

1Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
2Department of Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA
3Department of Nuclear Medicine, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
4Department of Biostatistics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA

Received 5 December 2011; Revised 3 March 2012; Accepted 6 March 2012

Academic Editor: Mario Santinami

Copyright © 2012 Rodrigo Arrangoiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Christenson, T. A. Borrowman, C. M. Vachon et al., “Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years,” Journal of the American Medical Association, vol. 294, no. 6, pp. 681–690, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. T. Greenlee, M. B. Hill-Harmon, T. Murray, and M. Thun, “Cancer statistics, 2001,” Ca-A Cancer Journal for Clinicians, vol. 51, no. 1, pp. 15–36, 2001. View at Google Scholar · View at Scopus
  4. R. A. Desmond and S. J. Soong, “Epidemiology of malignant melanoma,” Surgical Clinics of North America, vol. 83, no. 1, pp. 1–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Wahl, G. D. Hutchins, D. J. Buchsbaum, M. Liebert, H. Barton Grossman, and S. Fisher, “18F-2-deoxy-2-fluoro-d-glucose uptake into human tumor xenografts: Feasibility studies for cancer imaging with positron-emission tomography,” Cancer, vol. 67, no. 6, pp. 1544–1550, 1991. View at Google Scholar · View at Scopus
  6. K. A. Kern, “[14C]deoxyglucose uptake and imaging in malignant melanoma,” Journal of Surgical Research, vol. 50, no. 6, pp. 643–647, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Mijnhout, O. S. Hoekstra, A. Van Lingen et al., “How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma,” Journal of Clinical Pathology, vol. 56, no. 4, pp. 283–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. I. Longo, P. Lázaro, C. Bueno, J. L. Carreras, and R. Montz, “Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients,” Dermatologic Surgery, vol. 29, no. 3, pp. 245–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Hafner, M. Hess Schmid, W. Kempf et al., “Baseline staging in cutaneous malignant melanoma,” British Journal of Dermatology, vol. 150, no. 4, pp. 677–686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Wagner, D. Davidson, J. J. Coleman et al., “Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma,” Annals of Surgical Oncology, vol. 6, no. 4, pp. 398–404, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Wagner, D. Schauwecker, D. Davidson et al., “Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy,” Journal of Clinical Oncology, vol. 17, no. 5, pp. 1508–1515, 1999. View at Google Scholar · View at Scopus
  12. K. P. Friedman and R. L. Wahl, “Clinical use of positron emission tomography in the management of cutaneous melanoma,” Seminars in Nuclear Medicine, vol. 34, no. 4, pp. 242–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. P. Miranda, M. Gertner, J. Wall et al., “Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease,” Archives of Surgery, vol. 139, no. 8, pp. 831–837, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. B. Clark, V. Soo, J. Kraas, P. Shen, and E. A. Levine, “Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma,” Archives of Surgery, vol. 141, no. 3, pp. 284–288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Belhocine, G. Pierard, M. De Labrassinne, T. Lahaye, and P. Rigo, “Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection,” Oncologist, vol. 7, no. 4, pp. 271–278, 2002. View at Publisher · View at Google Scholar
  16. I. A. Ho Shon et al., “Imaging in cutaneous melanoma,” Nuclear Medicine Communications, vol. 29, no. 10, pp. 847–876, 2008. View at Google Scholar
  17. K. M. Acland, C. Healy, E. Calonje et al., “Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma,” Journal of Clinical Oncology, vol. 19, no. 10, pp. 2674–2678, 2001. View at Google Scholar · View at Scopus
  18. S. E. Finkelstein, J. A. Carrasquillo, J. M. Hoffman et al., “A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy,” Annals of Surgical Oncology, vol. 11, no. 8, pp. 731–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Acland, M. J. O'Doherty, and R. Russell-Jones, “The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma,” Journal of the American Academy of Dermatology, vol. 42, no. 4, pp. 606–611, 2000. View at Google Scholar · View at Scopus
  20. D. S. Tyler et al., “Positron emission tomography scanning in malignant melanoma,” Cancer, vol. 89, no. 5, pp. 1019–1025, 2000. View at Google Scholar
  21. A. Eigtved, A. P. Andersson, K. Dahlstrøm et al., “Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma,” European Journal of Nuclear Medicine, vol. 27, no. 1, pp. 70–75, 2000. View at Google Scholar · View at Scopus
  22. S. M. Swetter, L. A. Carroll, D. L. Johnson, and G. M. Segall, “Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients,” Annals of Surgical Oncology, vol. 9, no. 7, pp. 646–653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Kell, J. A. Ridge, N. Joseph, and E. R. Sigurdson, “PET CT imaging in patients undergoing sentinel node biopsy for melanoma,” European Journal of Surgical Oncology, vol. 33, no. 7, pp. 911–913, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Fink, S. Holle-Robatsch, N. Herzog et al., “Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II,” Melanoma Research, vol. 14, no. 2, pp. 141–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Havenga, D. C. P. Cobben, W. J. G. Oyen et al., “Fluorodeoxyglycose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma,” European Journal of Surgical Oncology, vol. 29, no. 8, pp. 662–664, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Crippa, M. Leutner, F. Belli et al., “Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma,” Journal of Nuclear Medicine, vol. 41, no. 9, pp. 1491–1494, 2000. View at Google Scholar · View at Scopus